CN1449784A - 复方莪术油制剂及其制备方法 - Google Patents
复方莪术油制剂及其制备方法 Download PDFInfo
- Publication number
- CN1449784A CN1449784A CN 03109769 CN03109769A CN1449784A CN 1449784 A CN1449784 A CN 1449784A CN 03109769 CN03109769 CN 03109769 CN 03109769 A CN03109769 A CN 03109769A CN 1449784 A CN1449784 A CN 1449784A
- Authority
- CN
- China
- Prior art keywords
- preparation
- oleum curcumae
- water
- add
- weighing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 53
- 150000001875 compounds Chemical class 0.000 title claims abstract description 27
- 240000009138 Curcuma zedoaria Species 0.000 title claims abstract description 18
- 235000003405 Curcuma zedoaria Nutrition 0.000 title claims abstract description 18
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 title claims abstract description 18
- 235000019509 white turmeric Nutrition 0.000 title claims abstract description 18
- 238000000034 method Methods 0.000 title claims description 6
- 239000010681 turmeric oil Substances 0.000 title abstract 2
- 230000008569 process Effects 0.000 title description 3
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 20
- SODWJACROGQSMM-UHFFFAOYSA-N 5,6,7,8-tetrahydronaphthalen-1-amine Chemical compound C1CCCC2=C1C=CC=C2N SODWJACROGQSMM-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229960003645 econazole nitrate Drugs 0.000 claims abstract description 19
- 239000003921 oil Substances 0.000 claims abstract description 17
- 239000000829 suppository Substances 0.000 claims abstract description 14
- 239000002775 capsule Substances 0.000 claims abstract description 8
- 206010046914 Vaginal infection Diseases 0.000 claims abstract description 5
- 230000003628 erosive effect Effects 0.000 claims abstract description 4
- 238000003756 stirring Methods 0.000 claims description 26
- 239000000203 mixture Substances 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- 238000005303 weighing Methods 0.000 claims description 18
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 17
- 235000019198 oils Nutrition 0.000 claims description 16
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 15
- -1 Polyoxyethylene stearate Polymers 0.000 claims description 15
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 15
- 239000007788 liquid Substances 0.000 claims description 13
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 12
- 229950005162 benexate Drugs 0.000 claims description 12
- IAXUQWSLRKIRFR-SAABIXHNSA-N chembl2104696 Chemical compound C1C[C@@H](CNC(=N)N)CC[C@@H]1C(=O)OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 IAXUQWSLRKIRFR-SAABIXHNSA-N 0.000 claims description 12
- 239000003292 glue Substances 0.000 claims description 10
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 9
- 229920002125 Sokalan® Polymers 0.000 claims description 9
- 229960001631 carbomer Drugs 0.000 claims description 9
- 239000000758 substrate Substances 0.000 claims description 8
- 201000010099 disease Diseases 0.000 claims description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 7
- 235000005979 Citrus limon Nutrition 0.000 claims description 6
- 244000131522 Citrus pyriformis Species 0.000 claims description 6
- 229920000858 Cyclodextrin Polymers 0.000 claims description 6
- 108010010803 Gelatin Proteins 0.000 claims description 6
- 239000002671 adjuvant Substances 0.000 claims description 6
- 239000012153 distilled water Substances 0.000 claims description 6
- 150000002148 esters Chemical class 0.000 claims description 6
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 claims description 6
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 claims description 6
- 239000008273 gelatin Substances 0.000 claims description 6
- 229920000159 gelatin Polymers 0.000 claims description 6
- 235000019322 gelatine Nutrition 0.000 claims description 6
- 235000011852 gelatine desserts Nutrition 0.000 claims description 6
- 235000011187 glycerol Nutrition 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 6
- 229920000053 polysorbate 80 Polymers 0.000 claims description 6
- 235000012424 soybean oil Nutrition 0.000 claims description 6
- 239000003549 soybean oil Substances 0.000 claims description 6
- 239000004408 titanium dioxide Substances 0.000 claims description 6
- 229940099259 vaseline Drugs 0.000 claims description 6
- 239000000499 gel Substances 0.000 claims description 5
- GYCKQBWUSACYIF-UHFFFAOYSA-N o-hydroxybenzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1O GYCKQBWUSACYIF-UHFFFAOYSA-N 0.000 claims description 5
- 239000004698 Polyethylene Substances 0.000 claims description 4
- 239000002552 dosage form Substances 0.000 claims description 4
- 238000000465 moulding Methods 0.000 claims description 4
- 229920000573 polyethylene Polymers 0.000 claims description 4
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 3
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 3
- 229920002535 Polyethylene Glycol 1500 Polymers 0.000 claims description 3
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 3
- 239000012467 final product Substances 0.000 claims description 3
- 238000007654 immersion Methods 0.000 claims description 3
- 238000012856 packing Methods 0.000 claims description 3
- 229940093430 polyethylene glycol 1500 Drugs 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 238000010257 thawing Methods 0.000 claims description 3
- 239000001116 FEMA 4028 Substances 0.000 claims description 2
- 201000008100 Vaginitis Diseases 0.000 claims description 2
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 2
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims description 2
- 229960004853 betadex Drugs 0.000 claims description 2
- NNGQLSIGRSTLLU-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)-2-[(2,6-dichlorophenyl)methoxy]ethyl]imidazole;nitric acid Chemical compound O[N+]([O-])=O.ClC1=CC(Cl)=CC=C1C(OCC=1C(=CC=CC=1Cl)Cl)CN1C=NC=C1 NNGQLSIGRSTLLU-UHFFFAOYSA-N 0.000 claims 1
- 239000002202 Polyethylene glycol Substances 0.000 claims 1
- 239000012530 fluid Substances 0.000 claims 1
- 229920001223 polyethylene glycol Polymers 0.000 claims 1
- 235000003392 Curcuma domestica Nutrition 0.000 abstract description 6
- 235000003373 curcuma longa Nutrition 0.000 abstract description 6
- 235000013976 turmeric Nutrition 0.000 abstract description 6
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract description 4
- 229940116229 borneol Drugs 0.000 abstract description 4
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract description 4
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract description 4
- 244000008991 Curcuma longa Species 0.000 abstract 1
- 208000016908 Female Genital disease Diseases 0.000 abstract 1
- 208000006374 Uterine Cervicitis Diseases 0.000 abstract 1
- 206010008323 cervicitis Diseases 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 208000002003 vulvitis Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 26
- LEZWWPYKPKIXLL-UHFFFAOYSA-N 1-{2-(4-chlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl}imidazole Chemical compound C1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 LEZWWPYKPKIXLL-UHFFFAOYSA-N 0.000 description 24
- 229960003913 econazole Drugs 0.000 description 24
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 description 18
- RFHAOTPXVQNOHP-UHFFFAOYSA-N fluconazole Chemical compound C1=NC=NN1CC(C=1C(=CC(F)=CC=1)F)(O)CN1C=NC=N1 RFHAOTPXVQNOHP-UHFFFAOYSA-N 0.000 description 18
- 229960004125 ketoconazole Drugs 0.000 description 18
- 229960000988 nystatin Drugs 0.000 description 17
- VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 17
- 229960004022 clotrimazole Drugs 0.000 description 16
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 description 16
- BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 description 15
- 229960002509 miconazole Drugs 0.000 description 15
- 230000000694 effects Effects 0.000 description 14
- 229940079593 drug Drugs 0.000 description 13
- 241000894006 Bacteria Species 0.000 description 9
- 241000222122 Candida albicans Species 0.000 description 8
- 230000000844 anti-bacterial effect Effects 0.000 description 7
- 229940095731 candida albicans Drugs 0.000 description 7
- 244000163122 Curcuma domestica Species 0.000 description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 5
- 241000222173 Candida parapsilosis Species 0.000 description 3
- 241001363490 Monilia Species 0.000 description 3
- 241000235645 Pichia kudriavzevii Species 0.000 description 3
- 241000222126 [Candida] glabrata Species 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 208000032343 candida glabrata infection Diseases 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 241000589220 Acetobacter Species 0.000 description 2
- 241000228245 Aspergillus niger Species 0.000 description 2
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 2
- 241001508813 Clavispora lusitaniae Species 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 244000285963 Kluyveromyces fragilis Species 0.000 description 2
- 235000014663 Kluyveromyces fragilis Nutrition 0.000 description 2
- 241000893976 Nannizzia gypsea Species 0.000 description 2
- 241000283898 Ovis Species 0.000 description 2
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 2
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 2
- 241000223238 Trichophyton Species 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 229940121375 antifungal agent Drugs 0.000 description 2
- 150000003851 azoles Chemical class 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 229940055022 candida parapsilosis Drugs 0.000 description 2
- 230000002079 cooperative effect Effects 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 229940093429 polyethylene glycol 6000 Drugs 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- MCCACAIVAXEFAL-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole;nitric acid Chemical compound O[N+]([O-])=O.ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 MCCACAIVAXEFAL-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 241000235036 Debaryomyces hansenii Species 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229960005040 miconazole nitrate Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000005142 microbroth dilution method Methods 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical class CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 03109769 CN1208057C (zh) | 2003-04-18 | 2003-04-18 | 复方莪术油制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 03109769 CN1208057C (zh) | 2003-04-18 | 2003-04-18 | 复方莪术油制剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1449784A true CN1449784A (zh) | 2003-10-22 |
CN1208057C CN1208057C (zh) | 2005-06-29 |
Family
ID=28683939
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 03109769 Expired - Lifetime CN1208057C (zh) | 2003-04-18 | 2003-04-18 | 复方莪术油制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1208057C (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100360172C (zh) * | 2005-12-09 | 2008-01-09 | 韩志强 | 复方莪术油栓在制备治疗脱屑性阴道炎药物中的应用 |
WO2010012131A1 (zh) * | 2008-07-28 | 2010-02-04 | Chen Rong | 含有莪术油的药物组合物的制药用途 |
CN103520635A (zh) * | 2013-10-11 | 2014-01-22 | 哈尔滨欧替药业有限公司 | 复方莪术油阴道膨胀栓及其制备方法和检测方法 |
CN104324382A (zh) * | 2013-07-22 | 2015-02-04 | 广州五丰动物保健品有限公司 | 一种莪术油-β-环糊精包合物及制备方法 |
CN107080817A (zh) * | 2017-05-04 | 2017-08-22 | 上海市静安区芷江西路街道社区卫生服务中心 | 一种新型妇科千金莪术油栓 |
CN109481462A (zh) * | 2018-11-20 | 2019-03-19 | 王清峰 | 一种治疗牛皮癣鹅掌风的化学药物及其制备方法 |
-
2003
- 2003-04-18 CN CN 03109769 patent/CN1208057C/zh not_active Expired - Lifetime
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100360172C (zh) * | 2005-12-09 | 2008-01-09 | 韩志强 | 复方莪术油栓在制备治疗脱屑性阴道炎药物中的应用 |
WO2010012131A1 (zh) * | 2008-07-28 | 2010-02-04 | Chen Rong | 含有莪术油的药物组合物的制药用途 |
CN104324382A (zh) * | 2013-07-22 | 2015-02-04 | 广州五丰动物保健品有限公司 | 一种莪术油-β-环糊精包合物及制备方法 |
CN103520635A (zh) * | 2013-10-11 | 2014-01-22 | 哈尔滨欧替药业有限公司 | 复方莪术油阴道膨胀栓及其制备方法和检测方法 |
CN103520635B (zh) * | 2013-10-11 | 2016-01-20 | 哈尔滨欧替药业有限公司 | 复方莪术油阴道膨胀栓及其制备方法和检测方法 |
CN107080817A (zh) * | 2017-05-04 | 2017-08-22 | 上海市静安区芷江西路街道社区卫生服务中心 | 一种新型妇科千金莪术油栓 |
CN107080817B (zh) * | 2017-05-04 | 2020-05-12 | 上海市静安区芷江西路街道社区卫生服务中心 | 一种新型妇科千金莪术油栓 |
CN109481462A (zh) * | 2018-11-20 | 2019-03-19 | 王清峰 | 一种治疗牛皮癣鹅掌风的化学药物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1208057C (zh) | 2005-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1762967A (zh) | 甘草次酸衍生物、制备方法及其用途 | |
CN1708312A (zh) | 新的天然来源的葡萄糖苷酶抑制剂 | |
CN1729007A (zh) | 用于预防和治疗炎性疾病,自体免疫性疾病,和移植排斥的组成物及方法 | |
CN1449784A (zh) | 复方莪术油制剂及其制备方法 | |
CN1628662A (zh) | 具有镇痛作用的药物 | |
CN1159015C (zh) | 二苯乙烯甙在治疗痴呆症中的用途 | |
CN1883645A (zh) | 一组主要治疗痤疮的组合物 | |
CN1732913A (zh) | 一种稳定性好的棓丙酯注射液及其制备方法 | |
CN1500487A (zh) | 左西替利嗪伪麻黄碱复方口服制剂及制备方法 | |
CN1923211A (zh) | 一种黄芪甲苷注射液及其制备方法 | |
CN1772122A (zh) | 一种具有消炎、解毒功效的了哥王制剂 | |
CN101077873A (zh) | 新的neo-克罗烷型二萜化合物及其应用 | |
CN1745781A (zh) | 一种治疗肛肠疾病的外用中药制剂 | |
CN1029771C (zh) | 斑蝥素脂溶性制剂的制备 | |
CN1602945A (zh) | 通窍鼻炎软胶囊及其制备工艺 | |
CN1076966C (zh) | 大黄素在制备延缓慢性肾衰的药物中的应用 | |
CN1593453A (zh) | 一种杀菌、抑菌药物组合物及其制剂和制备工艺 | |
CN1186026C (zh) | 羟乙葛根素在制备治疗缺血性脑血管病新药中的应用 | |
CN1303987C (zh) | 注射用盐酸艾司洛尔冻干粉针剂及其制备方法 | |
CN1555795A (zh) | 注射用盐酸昂丹司琼冻干粉针剂及制备方法 | |
CN1616018A (zh) | 一种提高生物利用度及药效治疗妇科疾病的制剂和制备方法 | |
CN1554367A (zh) | 治疗上呼吸道感染的药物 | |
CN1559535A (zh) | 一种治疗泌尿系感染的中药口服制剂及其制备方法 | |
CN1679793A (zh) | 一种消癌平制剂及其制备方法 | |
CN1274311C (zh) | 达玛烷型皂苷人参低元醇衍生物的制药用途及其制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: HAN ZHIQIANG Free format text: FORMER OWNER: TAIYANGSHI (TANGSHAN) PHARMACEUTICAL CO. LTD. Effective date: 20060303 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20060303 Address after: 063020 Torch Road, Tangshan City hi tech Development Zone, Hebei Patentee after: Han Zhiqiang Address before: 063020 Torch Road, Tangshan City hi tech Development Zone, Hebei Patentee before: SUNSTONE (TANGSHAN) PHARMACEUTICAL CO.,LTD. |
|
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: SUNSTONE (TANGSHAN) PHARMACEUTICAL CO.,LTD. Assignor: Han Zhiqiang Contract fulfillment period: 2007.09.05 to 2023.04.18 Contract record no.: 2007990000067 Denomination of invention: Compound curcuma oil preparation and preparation method thereof Granted publication date: 20050629 License type: Exclusive license Record date: 20071012 |
|
LIC | Patent licence contract for exploitation submitted for record |
Free format text: EXCLUSIVE LICENCE; TIME LIMIT OF IMPLEMENTING CONTACT: 2007.9.5 TO 2023.4.18 Name of requester: TAIYANGSHI (TANGSHAN) PHARMACEUTICAL CO. LTD. Effective date: 20071012 |
|
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: SUNSTONE (TANGSHAN) PHARMACEUTICAL CO.,LTD. Assignor: Han Zhiqiang Contract fulfillment period: 2009.10.20 to 2011.10.19 Contract record no.: 2009990001294 Denomination of invention: Compound zedoary turmeric oil preparation and preparation method thereof Granted publication date: 20050629 License type: General permission Record date: 20091127 Assignee: SUNSTONE (TANGSHAN) PHARMACEUTICAL CO.,LTD. Assignor: Han Zhiqiang Contract fulfillment period: 2009.12.16 to 2026.5.30 Contract record no.: 2009990001331 Denomination of invention: Compound zedoary turmeric oil preparation and preparation method thereof Granted publication date: 20050629 License type: Exclusive license Record date: 20091217 |
|
LIC | Patent licence contract for exploitation submitted for record |
Free format text: COMMON LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2009.10.20 TO 2011.10.19; CHANGE OF CONTRACT Name of requester: TAIYANGSHI (TANGSHAN) PHARMACEUTICAL CO. LTD. Effective date: 20091127 Free format text: EXCLUSIVE LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2009.12.16 TO 2026.5.30; CHANGE OF CONTRACT Name of requester: TAIYANGSHI (TANGSHAN) PHARMACEUTICAL CO. LTD. Effective date: 20091217 |
|
ASS | Succession or assignment of patent right |
Owner name: SUNSTONE (TANGSHAN) PHARMA CO., LTD. Free format text: FORMER OWNER: HAN ZHIQIANG Effective date: 20101125 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 063020 TORCH ROAD, NEW + HIGH TECHNOLOGY DEVELOPMENT ZONE, TANGSHAN CITY, HEBEI PROVINCE TO: 063020 NO.139, TORCH ROAD, NEW + HIGH TECHNOLOGY DEVELOPMENT ZONE, TANGSHAN CITY, HEBEI PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20101125 Address after: 063020 Torch Road, Tangshan City hi tech Development Zone, Hebei 139, China Patentee after: SUNSTONE (TANGSHAN) PHARMACEUTICAL CO.,LTD. Address before: 063020 Torch Road, Tangshan City hi tech Development Zone, Hebei Patentee before: Han Zhiqiang |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 063020 Torch Road, Tangshan City hi tech Development Zone, Hebei 139, China Patentee after: China Resources Sanjiu (Tangshan) Pharmaceutical Co.,Ltd. Address before: 063020 Torch Road, Tangshan City hi tech Development Zone, Hebei 139, China Patentee before: SUNSTONE (TANGSHAN) PHARMACEUTICAL Co.,Ltd. |
|
CX01 | Expiry of patent term |
Granted publication date: 20050629 |
|
CX01 | Expiry of patent term |